RT Journal Article
SR Electronic
A1 Nichols, Emma Hitt
T1 Sentinel Lymph Node Biopsy before or after Neoadjuvant Chemotherapy: Final Results from the SENTINA Trial
JF MD Conference Express
YR 2013
FD SAGE Publications
VO 12
IS 20
SP 14
OP 14
DO 10.1177/155989771220011
UL http://mdc.sagepub.com/content/12/20/14.1.abstract
AB For patients with breast cancer who undergo primary surgery, sentinel lymph node biopsy (SLNB) is the standard staging procedure to determine the axillary status when the patient is clinically node negative [D'Angelo-Donovan DD et al. Surg Oncol 2012]. However, for patients who undergo neoadjuvant chemotherapy, the optimal role and timing of SLNB is still unclear. This article presents final results from the prospective German, multi-institutional Sentinel Neoadjuvant [SENTINA] trial.